Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly gets nod to launch weight-loss drug in Hong Kong
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
Oct 27 (Reuters) -
Eli
Lilly
(LLY.N), opens new tab expects to start selling its weight-loss drug in
Hong
Kong
as early as the end of this year, Bloomberg
News
reported, opens new tab on Sunday. The drugmaker has received approval from the
Hong
Kong
...
Eli Lilly gets nod to sell weight-loss drug in Hong Kong by year-end - report
Eli Lilly (NYSE:LLY) received approval from the Hong Kong government to launch its weight-loss drug—Mounjaro, with sales expected to begin as early as year-end, Bloomberg reported. The company got approval to sell its tirzepatide injections—branded as Mounjaro—in a device called Kwikpen.
Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong
Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the end of this year after the company gained the Hong Kong government approval to sell the drug in a device called Kwikpen for both long-term weight management and type 2 diabetes,
Eli Lilly Set to Launch Weight-Loss Drug Mounjaro in Hong Kong by Year-End
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this
Eli Lilly Gets Nod to Launch Blockbuster Weight-Loss Drug in Hong Kong
Eli Lilly & Co. expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, potentially making it the first of its kind to become available in the China region.
Eli Lilly’s weight-loss drug Mounjaro set for Hong Kong launch - report
Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of this year, potentially becoming the first drug of its kind available in the broader China region,
Alphabet, Eli Lilly and Wall Street
Stock market today: Nasdaq edges back from its record as chip companies and Eli Lilly slump
U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company. The S&P 500 slipped 0.3% Wednesday.
Stock market today: Wall Street indexes edge lower as Alphabet jumps and Eli Lilly slumps
U.S. stock indexes gave up an early gain and ended slightly lower following a mixed set of profit reports from giants like Google’s parent company and Eli Lilly
Alphabet earnings: Stock climbs as Wall Street reacts to upbeat growth
Alphabet reported earnings after Tuesday's closing bell. MarketWatch will be breaking down the results and reactions.
The Associated Press on MSN
1h
Stock market today: Asia shares decline as investors await earnings, US elections and economic data
Japan's benchmark Nikkei 225 dipped 0.5% in early trading to 39,069.20. Hong Kong's Hang Seng rose 0.3% to 20,433.83, while the Shanghai Composite fell 0.3% to 3,258.04. Details of the long-range ...
devdiscourse
3d
Major Developments in Health Industry: New Drug Approval, E. coli Safety, and Corporate Controversies
This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.
16h
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Eli Lilly said it sees fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of $45.4 billion—$46.6 ...
3d
Wall Street Breakfast Podcast: Volkswagen Readies $4.3B Cost-Cutting Plan
Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...
The Herald Bulletin
21h
Stock market today: Wall Street churns as profit reports come in mixed
A mixed set of profit reports from giants like Google’s parent company and Eli Lilly has stock indexes churning in place on ...
2d
McDonald's, Eli Lilly, Apple: 3 stocks in focus
Morning Brief Hosts Seana Smith and Brad Smith check in on some of Yahoo Finance's top trending tickers: McDonald's (MCD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback